Hints and tips:
...Its investment in NSO, which has a parent company domiciled in Luxembourg but is based in Herzliya, Israel, valued the company at about $1bn....
...Teva, an Israel-based pharma company, will aim to increase access to medicine in poor and middle-income countries and reduce its greenhouse gas emissions....
...*This story has been amended to indicate that Teva is an Israel-based drugmaker....
...The jab is by far the most widely used vaccine in the UAE’s nationwide effort that has helped the country deliver 81 doses per 100 people, second only to Israel among populous nations....
...Only Israel and the United Arab Emirates, among larger countries, have inoculated more per head of the population....
...The China-manufactured Covid-19 vaccine has driven the UAE’s successful vaccine campaign which has delivered 67 doses per 100 residents, second only to Israel in countries with a sizeable population....
...On Tuesday, Israel’s Teva became the seventh drugmaker to be charged in the US with conspiring to fix the price of generic drugs....
...Rivals from Israel, Japan and America are competing to do the same, while often sourcing components from the US....
...The Israel-based drugmaker forecast revenues of between $17bn and $17.4bn this year, below the average analyst estimate for $17.9bn....
...in sectors ranging from construction and pharmaceuticals to banking....
...Teva’s New York-listed shares were up 6 per cent to $23.83 after the US Food and Drug Administration gave the go-ahead to the Israel-based company....
...The likes of Teva, Mylan and Perrigo could boast 30 per cent operating margins as their positions as unbranded providers themselves were almost as protected as the drugs they replaced....
...The industry is dominated by four major companies - Givaudan, Firmenich, IFF, and Symrise - which provide flavours and fragrances for use in food, beverages and pharmaceuticals....
...Shares in Israel’s Teva Pharmaceutical, the world’s largest generic drugmaker, fell sharply after it forecast a drop in revenue in 2018 in spite of aggressive cost-cutting that will lose as many as 14,000...
...He sold his remaining stake to GlaxoSmithKline in 2011, when the pharmaceutical company bought the brand for £162m....
...The head of Israel’s national trade union has called for a half-day strike on Sunday over reports that Teva Pharmaceutical intends to announce massive layoffs in Israel on Thursday....
...The pharmaceuticals group did not say where it would make the cuts, which are equivalent to a quarter of its global workforce, although unions fear the company’s roughly 7,000 Israeli workers will bear the...
...“Imagine there is a pharmaceutical product that is now off-patent that used to cost $100 a month but now is $5 a month generic,” said Mr Schultz....
...The pharmaceuticals group did not say where it would make the cuts, equivalent to 25 per cent of its global workforce, although unions fear the company’s roughly 7,000 Israeli workers will bear the brunt...
...Shares in generic drugmakers are tumbling, after one of the largest, Perrigo, said its offices had been searched by investigators conducting a federal probe on price collusion....
...Another swashbuckler two summers ago, it courted rivals Perrigo and Mylan, then spent $40bn acquiring the generics unit of Allergan....
...Australia joins Canada, Israel, the Netherlands and Uruguay in targeting the fast-growing legal global marijuana market, which forecasters predict could be worth $63.5bn by 2024....
...“Politically, you have a very thorny issue to deal with in Israel.”...
...Mylan’s announcement comes as a major blow for Israel’s Teva, which is groaning under $35bn of debts amassed during a borrowing-fuelled acquisition spree that saw the company double down on generic drugs...
...Two large pharmaceutical companies are set to unveil more than £1bn of investment in research hubs in the UK in a much needed boost for Theresa May’s vision of a vibrant post-Brexit economy....
International Edition